PH18930A - 2-phenyl-pyrimidones - Google Patents

2-phenyl-pyrimidones

Info

Publication number
PH18930A
PH18930A PH26759A PH26759A PH18930A PH 18930 A PH18930 A PH 18930A PH 26759 A PH26759 A PH 26759A PH 26759 A PH26759 A PH 26759A PH 18930 A PH18930 A PH 18930A
Authority
PH
Philippines
Prior art keywords
pyrimidones
phenyl
Prior art date
Application number
PH26759A
Other languages
English (en)
Inventor
Joachim Heider
Volkhard Austel
Wolfgang Eberlein
Rudolf Kadatz
Christian Lillie
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PH18930A publication Critical patent/PH18930A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
PH26759A 1980-12-12 1981-12-11 2-phenyl-pyrimidones PH18930A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
PH18930A true PH18930A (en) 1985-11-11

Family

ID=25789685

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26759A PH18930A (en) 1980-12-12 1981-12-11 2-phenyl-pyrimidones

Country Status (22)

Country Link
US (1) US4379788A (es)
EP (1) EP0054132B1 (es)
AR (1) AR227567A1 (es)
AU (1) AU543568B2 (es)
CA (1) CA1217767A (es)
CS (1) CS227024B2 (es)
DD (1) DD208151A5 (es)
DE (1) DE3166627D1 (es)
DK (1) DK525481A (es)
ES (2) ES507761A0 (es)
FI (1) FI813971L (es)
GB (1) GB2090249B (es)
GR (1) GR76952B (es)
HU (1) HU187384B (es)
IL (1) IL64504A (es)
MY (1) MY8700562A (es)
NO (1) NO814239L (es)
NZ (1) NZ199254A (es)
PH (1) PH18930A (es)
PL (1) PL135330B1 (es)
PT (1) PT74116B (es)
SU (1) SU1056900A3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
CN100430396C (zh) 1997-11-12 2008-11-05 拜耳医药保健股份公司 用作磷酸二酯酶抑制剂的2-苯基取代的咪唑并三嗪酮
AU2645299A (en) * 1998-11-18 2000-06-05 Elena Alexandrovna Izaxon 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
CN1518447A (zh) * 2001-04-23 2004-08-04 �������Ǵ�ѧר������� 作为抗血管生成剂的新的苯邻二甲酰亚胺模拟物的合成和评估
DE50209015D1 (de) * 2001-05-09 2007-02-01 Bayer Healthcare Ag NEUE VERWENDUNG VON 2-Ä2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenylÜ-5-methyl-7-propyl-3H-imidazoÄ5,1-fÜÄ1,2,4Ütriazin-4-on
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
EP1696927A4 (en) * 2003-12-19 2007-10-31 Merck & Co Inc MITOTIC INHIBITORS OF KINESIN
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
JPWO2005115993A1 (ja) * 2004-05-31 2008-03-27 萬有製薬株式会社 キナゾリン誘導体
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
EP1931797A2 (en) * 2005-09-29 2008-06-18 Bayer HealthCare AG Pde inhibitors and combinations thereof for the treatment of urological disorders
CA2663436A1 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
CN101711153A (zh) * 2007-06-13 2010-05-19 拜耳先灵制药股份公司 用于治疗听觉损伤的pde抑制剂
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
CN102098918A (zh) * 2008-05-13 2011-06-15 帕纳德制药公司 用于治疗癌症和神经退行性疾病的生物活性化合物
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
KR102200628B1 (ko) * 2012-09-26 2021-01-08 메르크 파텐트 게엠베하 Parp 억제제로서의 퀴나졸리논 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Also Published As

Publication number Publication date
DD208151A5 (de) 1984-03-28
NZ199254A (en) 1985-02-28
FI813971L (fi) 1982-06-13
IL64504A (en) 1985-02-28
CA1217767A (en) 1987-02-10
DE3166627D1 (en) 1984-11-15
AU543568B2 (en) 1985-04-26
SU1056900A3 (ru) 1983-11-23
GR76952B (es) 1984-09-04
US4379788A (en) 1983-04-12
ES8207156A1 (es) 1982-09-01
CS227024B2 (en) 1984-04-16
GB2090249A (en) 1982-07-07
AU7847381A (en) 1982-06-17
ES8304096A1 (es) 1983-02-16
EP0054132A1 (de) 1982-06-23
MY8700562A (en) 1987-12-31
AR227567A1 (es) 1982-11-15
PL234175A1 (es) 1982-08-16
IL64504A0 (en) 1982-03-31
PL135330B1 (en) 1985-10-31
DK525481A (da) 1982-06-13
NO814239L (no) 1982-06-14
PT74116A (de) 1982-01-01
PT74116B (de) 1983-12-19
ES511835A0 (es) 1983-02-16
GB2090249B (en) 1984-08-22
ES507761A0 (es) 1982-09-01
HU187384B (en) 1985-12-28
EP0054132B1 (de) 1984-10-10

Similar Documents

Publication Publication Date Title
CS23281A2 (en) Zpusob vyroby novych retardovanych forem dipyridamolu
PH18930A (en) 2-phenyl-pyrimidones
CS339581A2 (en) Zpusob vyroby novych oxiranu
CS516281A2 (en) Zpusob pripravy vodne disperze castic filmotvorneho polymeru
CS386581A2 (en) Zaruvzdorne stavebni teleso
CS235681A2 (en) Zpusob vyroby mocovinovych granulek
CS34081A1 (en) Elektromagneticke upinaci zarizeni
CS403081A2 (en) Hydraulicky valec
IL63330A0 (en) 1-chloro-1-p-methoxybenzoylformaldoxime-n-methylcarbamate
CS54381A1 (en) Vnitrni vylozeni kulovych trubnatych mlynu
CS460181A1 (en) Kombinovany sorbentovy dialyzator
CS182781A1 (en) Zpusob regeneracniho vyuziti tepelneho obsahu nenasycenych roztoku
CS16981A2 (en) Zpusob vyroby cpavku
CS12981A2 (en) Zpusob pripravy benzenaminove slouceniny
CS227481A2 (en) Zpusob pripravy vincristinu
CS512381A2 (en) Pohon listu kruhoveho tkaciho stroje
CS198081A2 (en) Herbicidni prostredek
CS416981A1 (en) Fixacni zarizeni laboratornich odstredivek
CS54481A1 (en) Kapalinovy hasici pristroj
CS436281A1 (en) Skelet jizdniho ergometru
CS267081A1 (en) Hlava vicestupnoveho prevodu
CS302581A1 (en) Vzorkovnice vzorkovac
CS436381A1 (en) Ergometr
CS391481A1 (en) Stabilizator zivneho roztoku
CS233381A1 (en) Kancelarsky dirkovac skladne konstrukce